Sitagliptin Tablets IP 50Mg

Price 160 INR/ Unit

Get a Price/Quote

MOQ : 5000 Units

Sitagliptin Tablets IP 50Mg Specification

Salt Composition
Sitagliptin Phosphate Equiv. to Sitagliptin 50mg

Life Span
24 months from manufacturing date

Packaging Type
Blister Pack

Dosage Form
Tablet

Brand Name
Sitagliptin Tablets IP

Indication
Helps control blood sugar levels in patients with type 2 diabetes

Origin of Medicine
India

Pacakaging (Quantity Per Box)
100 tablets (10 strips of 10 tablets each)

Drug Type
Allopathic

Ingredients
Sitagliptin Phosphate Monohydrate

Physical Form
Tablets

Function
Antidiabetic, DPP-4 Inhibitor

Recommended For
Type 2 Diabetes Mellitus

Dosage
50 mg

Dosage Guidelines
As directed by a physician

Suitable For
Adults

Quantity
10 Tablets per strip

Storage Instructions
Keep in a Cool & Dry Place

Marketed By
Reputed pharmaceutical company

Prescription
Prescription only

Warning
Not for use in patients with type 1 diabetes or for the treatment of diabetic ketoacidosis

Drug Interactions
Consult healthcare professional before use with other antidiabetic agents

Side Effects
May include headache, upper respiratory tract infection, nasopharyngitis

Color
White to off-white

Imprint
Typically marked with dosage and batch details

Shape
Round, film-coated

Administration Route
Oral

Regulatory Compliance
IP (Indian Pharmacopoeia) standard

Sitagliptin Tablets IP 50Mg Trade Information

Minimum Order Quantity
5000 Units

Delivery Time
2-4 Days

About Sitagliptin Tablets IP 50Mg

Sitagliptin Tablets IP 50Mg-an epitome of laureate pharmaceutical excellence, crafted for adults managing type 2 diabetes mellitus. This trending marvel, presented in visually highlighted white to off-white, round, film-coated tablets, is a paragon of antidiabetic therapy. Imprinted with precise dosage and batch details, each tablet contains Sitagliptin Phosphate Monohydrate, delivering 50mg strength as DPP-4 inhibitor. Add to Cart for superior blood sugar control, with safety, compliance, and ease, packaged securely in blister packs by a reputed Indian distributor. For prescription use only.

Plant Application and Exceptional Features

Sitagliptin Tablets IP 50Mg are meticulously manufactured under stringent IP (Indian Pharmacopoeia) standards, making them suitable for various healthcare settings-hospitals, clinics, and pharmacies. Noteworthy features include their film-coated, round form for easy oral administration, clear imprinting for traceability, and long shelf life (24 months). This allopathic, antidiabetic paragon is expertly recommended for adult patients with type 2 diabetes, providing effective and consistent glycemic control.

Domestic Market Reach and Delivery Protocols

The main domestic market for Sitagliptin Tablets IP 50Mg is India, with a well-established distribution network enabling prompt handover to healthcare establishments nationwide. Each consignment is packaged in boxes containing 100 tablets and efficiently managed through optimal transportation channels. Reliable exchange and sample policies ensure customer satisfaction, making the procurement of Sitagliptin Tablets seamless, whether by distributor, supplier, importer, or trader.

FAQ's of Sitagliptin Tablets IP 50Mg:

Q: How should Sitagliptin Tablets IP 50Mg be administered?

A: Sitagliptin Tablets are for oral use and should be taken exactly as directed by your physician, typically once daily. Swallow the tablet whole with water without crushing or chewing it.

Q: What are the primary benefits of using Sitagliptin Tablets IP 50Mg?

A: These tablets help control blood glucose levels in adults with type 2 diabetes mellitus, improving overall glycemic management and reducing the risk of diabetes complications when used as prescribed.

Q: When should one avoid using Sitagliptin Tablets IP 50Mg?

A: Sitagliptin Tablets should not be used in patients with type 1 diabetes or for the treatment of diabetic ketoacidosis. Always consult your healthcare provider to ensure suitability.

Q: Where are Sitagliptin Tablets IP 50Mg manufactured and marketed?

A: These tablets are manufactured and marketed by a reputed pharmaceutical company in India and comply with Indian Pharmacopoeia (IP) standards.

Q: What precautions should be considered before starting Sitagliptin Tablets IP 50Mg?

A: Consult your healthcare professional about possible drug interactions, particularly with other antidiabetic medications, and discuss any medical conditions or allergies you may have.